EGFR and adenocarcinoma: EGFR mutations have been reported in 47.9% of adenocarcinomas and 4.6% of squamous cell carcinomas in Asian populations, and 19.2% of adenocarcinomas and 3.3% of squamous cell carcinomas in Western populations, and are rare in squamous cell carcinomas [4].